Dyne Therapeutics, Inc. (DYN)

SEC filing

Dyne Therapeutics, Inc.

DYN · CIK 1818794

4 · Sep 8, 2026 · Chief Commercial Officer Friedl-Naderer Johanna sold 1,085 shares at $23.42/share ($25,408)

Chief Commercial Officer Friedl-Naderer Johanna sold 1,085 shares at $23.42/share ($25,408)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.